$1.42 Billion is the total value of Rhenman & Partners Asset Management AB's 92 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 8.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $51,484,000 | +4.7% | 470,000 | -10.5% | 3.61% | +8.3% |
| UNH | UNITED HEALTH GROUP INC | $48,843,000 | -2.4% | 125,000 | 0.0% | 3.43% | +0.9% | |
| ANTM | Buy | ANTHEM INC | $44,736,000 | +23.3% | 120,000 | +26.3% | 3.14% | +27.5% |
| JNJ | Buy | JOHNSON & JOHNSON | $43,605,000 | +252.9% | 270,000 | +260.0% | 3.06% | +264.8% |
| PFE | Buy | PFIZER INC | $43,010,000 | +119.7% | 1,000,000 | +100.0% | 3.02% | +127.2% |
| BIIB | Buy | BIOGEN INC | $42,449,000 | +36.2% | 150,000 | +66.7% | 2.98% | +40.9% |
| ABBV | Buy | ABBVIE INC | $38,294,000 | +6.2% | 355,000 | +10.9% | 2.69% | +9.8% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $36,459,000 | -6.7% | 280,000 | +27.3% | 2.56% | -3.5% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $34,280,000 | +35.9% | 60,000 | +20.0% | 2.41% | +40.5% |
| MDT | MEDTRONIC PLC | $34,221,000 | +1.0% | 273,000 | 0.0% | 2.40% | +4.4% | |
| CVS | Buy | CVS HEALTH CORP | $33,944,000 | +7.1% | 400,000 | +5.3% | 2.38% | +10.7% |
| LLY | Buy | LILLY ELI & CO | $33,502,000 | +22.9% | 145,000 | +22.1% | 2.35% | +27.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $29,929,000 | -31.2% | 165,000 | -23.6% | 2.10% | -28.9% |
| MCK | Buy | MCKESSON CORP | $29,508,000 | +97.8% | 148,000 | +89.7% | 2.07% | +104.4% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $26,537,000 | -0.4% | 150,000 | -9.1% | 1.86% | +3.0% |
| GH | Buy | GUARDANT HEALTH INC | $25,627,000 | +17.9% | 205,000 | +17.1% | 1.80% | +22.0% |
| CI | Sell | CIGNA CORP NEW | $25,420,000 | -17.8% | 127,000 | -2.7% | 1.78% | -15.0% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $24,732,000 | +11.2% | 570,000 | +9.6% | 1.74% | +15.0% |
| ABT | Sell | ABBOTT LABS | $24,335,000 | -16.0% | 206,000 | -17.6% | 1.71% | -13.2% |
| SGEN | Sell | SEAGEN INC | $22,923,000 | -8.1% | 135,000 | -14.5% | 1.61% | -4.9% |
| ABMD | Buy | ABIOMED INC | $22,786,000 | +12.3% | 70,000 | +7.7% | 1.60% | +16.1% |
| MRK | MERCK & CO. INC | $22,533,000 | -3.4% | 300,000 | 0.0% | 1.58% | -0.1% | |
| ABC | Buy | AMERISOURCEBERGEN CORP | $22,457,000 | +13.4% | 188,000 | +8.7% | 1.58% | +17.3% |
| HUM | Buy | HUMANA INC | $22,182,000 | -8.9% | 57,000 | +3.6% | 1.56% | -5.8% |
| GILD | GILEAD SCIENCES INC | $20,955,000 | +1.4% | 300,000 | 0.0% | 1.47% | +4.9% | |
| ISRG | Sell | INTUITIVE SURGICAL INC | $19,883,000 | -3.9% | 20,000 | -11.1% | 1.40% | -0.6% |
| TDOC | Sell | TELADOC HEALTH INC | $19,022,000 | -45.5% | 150,000 | -28.6% | 1.34% | -43.7% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $18,876,000 | -21.7% | 290,000 | -23.7% | 1.32% | -19.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $18,881,000 | -17.5% | 100,000 | -25.9% | 1.32% | -14.7% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $18,753,000 | -3.6% | 135,000 | -32.6% | 1.32% | -0.4% |
| CNC | Buy | CENTENE CORP DEL | $18,693,000 | -1.4% | 300,000 | +15.4% | 1.31% | +1.9% |
| COO | COOPER COS INC | $18,599,000 | +4.3% | 45,000 | 0.0% | 1.30% | +7.9% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $18,550,000 | +39.0% | 240,000 | +50.0% | 1.30% | +43.7% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $18,499,000 | -4.0% | 561,269 | +84.0% | 1.30% | -0.8% |
| HCA | HCA HEALTHCARE INC | $18,204,000 | +17.4% | 75,000 | 0.0% | 1.28% | +21.4% | |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $17,563,000 | -22.0% | 120,000 | -14.3% | 1.23% | -19.3% |
| VEEV | Sell | VEEVA SYS INC | $17,290,000 | -25.9% | 60,000 | -20.0% | 1.21% | -23.3% |
| EXAS | Buy | EXACT SCIENCES CORP | $17,181,000 | -10.8% | 180,000 | +16.1% | 1.21% | -7.8% |
| NKTR | NEKTAR THERAPEUTICS | $17,062,000 | +4.7% | 950,000 | 0.0% | 1.20% | +8.2% | |
| XNCR | Buy | XENCOR INC | $16,559,000 | +41.2% | 507,002 | +49.1% | 1.16% | +46.0% |
| ITCI | INTRA CELLULAR THERAPIES INC | $16,020,000 | -8.7% | 429,728 | 0.0% | 1.12% | -5.6% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $14,408,000 | +95.0% | 750,000 | 0.0% | 1.01% | +101.8% | |
| BDX | Buy | BECTON DICKINSON & CO | $14,258,000 | +22.1% | 58,000 | +20.8% | 1.00% | +26.4% |
| ACCD | Buy | ACCOLADE INC | $13,705,000 | -15.9% | 325,000 | +8.3% | 0.96% | -13.0% |
| RCM | R1 RCM INC | $12,106,000 | -1.0% | 550,000 | 0.0% | 0.85% | +2.4% | |
| HCAT | HEALTH CATALYST INC | $12,002,000 | -9.9% | 240,000 | 0.0% | 0.84% | -6.9% | |
| THC | Buy | TENET HEALTHCARE CORP | $11,959,000 | +110.0% | 180,000 | +111.8% | 0.84% | +117.4% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $11,887,000 | +4.3% | 105,000 | -4.5% | 0.83% | +7.9% |
| MGNX | MACROGENICS INC | $11,416,000 | -22.0% | 545,160 | 0.0% | 0.80% | -19.4% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $9,111,000 | -10.8% | 95,000 | -9.5% | 0.64% | -7.9% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $8,915,000 | +11.4% | 320,000 | +18.5% | 0.63% | +15.3% |
| AERI | AERIE PHARMACEUTICALS INC | $8,550,000 | -28.8% | 750,000 | 0.0% | 0.60% | -26.4% | |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $8,505,000 | -22.0% | 420,000 | +27.3% | 0.60% | -19.4% |
| SILK | SILK ROAD MEDICAL INC | $8,034,000 | +15.0% | 146,000 | 0.0% | 0.56% | +19.0% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $7,891,000 | +1.1% | 320,000 | +6.7% | 0.55% | +4.5% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $7,853,000 | +178.2% | 204,876 | +104.9% | 0.55% | +187.0% |
| PHR | Sell | PHREESIA INC | $7,618,000 | -52.2% | 123,465 | -52.5% | 0.54% | -50.6% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $7,498,000 | -38.0% | 622,267 | +8.7% | 0.53% | -36.0% |
| BMY | BRISTOL MYERS SQUIBB CO | $7,396,000 | -11.5% | 125,000 | 0.0% | 0.52% | -8.5% | |
| GKOS | Buy | GLAUKOS CORP | $7,226,000 | +143.4% | 150,000 | +328.6% | 0.51% | +151.0% |
| SWAV | Buy | SHOCKWAVE MEDICAL INC | $7,000,000 | +8.5% | 34,000 | +0.0% | 0.49% | +12.1% |
| NVCR | Sell | NOVOCURE LTD | $6,970,000 | -73.8% | 60,000 | -50.0% | 0.49% | -72.9% |
| IMGN | IMMUNOGEN INC | $6,911,000 | -14.0% | 1,218,850 | 0.0% | 0.48% | -11.0% | |
| SGMO | SANGAMO THERAPEUTICS INC | $6,893,000 | -24.7% | 765,000 | 0.0% | 0.48% | -22.2% | |
| ALKS | Sell | ALKERMES PLC | $6,476,000 | -14.6% | 210,000 | -32.1% | 0.46% | -11.7% |
| PHAT | PHATHOM PHARMACEUTICALS INC | $5,977,000 | -5.2% | 186,210 | 0.0% | 0.42% | -1.9% | |
| MGTX | MEIRAGTX HLDGS PLC | $5,931,000 | -15.0% | 450,000 | 0.0% | 0.42% | -12.1% | |
| ISEE | New | IVERIC BIO INC | $5,684,000 | – | 350,000 | +100.0% | 0.40% | – |
| PRVA | New | PRIVIA HEALTH GROUP INC | $5,654,000 | – | 240,000 | +100.0% | 0.40% | – |
| MYOV | MYOVANT SCIENCES LTD | $5,610,000 | -1.5% | 250,000 | 0.0% | 0.39% | +2.1% | |
| VRAY | VIEWRAY INC | $5,588,000 | +9.2% | 775,000 | 0.0% | 0.39% | +13.0% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $5,518,000 | -16.4% | 1,520,000 | 0.0% | 0.39% | -13.6% | |
| RDUS | RADIUS HEALTH INC | $5,336,000 | -32.0% | 430,000 | 0.0% | 0.38% | -29.5% | |
| SAVA | Sell | CASSAVA SCIENCES INC | $5,277,000 | -46.3% | 85,000 | -26.1% | 0.37% | -44.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $5,096,000 | +19.6% | 115,000 | +53.3% | 0.36% | +23.9% |
| EPIX | Buy | ESSA PHARMA INC | $4,800,000 | -35.4% | 600,000 | +130.8% | 0.34% | -33.1% |
| ANNX | ANNEXON INC | $4,653,000 | -17.3% | 250,000 | 0.0% | 0.33% | -14.4% | |
| PGNY | PROGYNY INC | $4,480,000 | -5.1% | 80,000 | 0.0% | 0.31% | -1.9% | |
| OSH | Buy | OAK STR HEALTH INC | $4,466,000 | -19.7% | 105,000 | +10.5% | 0.31% | -17.2% |
| GTHX | G1 THERAPEUTICS INC | $4,362,000 | -38.8% | 325,000 | 0.0% | 0.31% | -36.8% | |
| STXS | Buy | STEREOTAXIS INC | $4,304,000 | -34.8% | 800,000 | +16.9% | 0.30% | -32.6% |
| ARNA | ARENA PHARMACEUTICALS INC | $3,573,000 | -12.7% | 60,000 | 0.0% | 0.25% | -9.7% | |
| OLK | New | OLINK HLDG ABsponsored ads | $3,395,000 | – | 140,000 | +100.0% | 0.24% | – |
| IMCR | IMMUNOCORE HLDGS PLCads | $3,336,000 | -5.1% | 90,000 | 0.0% | 0.23% | -2.1% | |
| IONS | IONIS PHARMACEUTICALS INC | $2,516,000 | -15.9% | 75,000 | 0.0% | 0.18% | -12.8% | |
| FGEN | FIBROGEN INC | $2,044,000 | -61.6% | 200,000 | 0.0% | 0.14% | -60.5% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $2,039,000 | -7.2% | 60,000 | 0.0% | 0.14% | -4.0% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,551,000 | +35.0% | 300,000 | 0.0% | 0.11% | +39.7% | |
| SBTX | Buy | SILVERBACK THERAPEUTICS INC | $1,497,000 | -51.5% | 150,000 | +50.0% | 0.10% | -50.0% |
| EPZM | EPIZYME INC | $1,357,000 | -38.4% | 265,000 | 0.0% | 0.10% | -36.2% | |
| INNV | INNOVAGE HLDG CORP | $992,000 | -69.0% | 150,000 | 0.0% | 0.07% | -67.7% | |
| XLRN | Sell | ACCELERON PHARMA INC | $756,000 | -97.0% | 4,392 | -97.8% | 0.05% | -96.9% |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -10,000 | -100.0% | -0.06% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -35,000 | -100.0% | -0.42% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -110,000 | -100.0% | -0.60% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -25,000 | -100.0% | -0.95% | – |
| INOV | Exit | INOVALON HLDGS INC | $0 | – | -600,000 | -100.0% | -1.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.